Back
EyePoint Pharmaceuticals Stock Price Chart

10 Stellar Stocks - get the names here
Learn their names here. FREE
Sell
14
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.49
Seasonality Move:
10.98%
7 Day Trial
ALL ACCESS PASS
$
7

Recent Tech Boom Could Send "EarnPhone" Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.
EyePoint Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.58 | Sell |
20-day SMA: | 7.39 | Sell |
50-day SMA: | 7.7 | Sell |
200-day SMA: | 9.28 | Sell |
8-day EMA: | 6.63 | Sell |
20-day EMA: | 7.13 | Sell |
50-day EMA: | 7.78 | Sell |
200-day EMA: | 9.89 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 39.78 | Sell |
Chaikin Money Flow: | 52994 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.68 - 8.22) | Sell |
Bollinger Bands (100): | (7.21 - 10.27) | Sell |
EyePoint Pharmaceuticals Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 6.50 while EYPT 8-day simple moving average is 6.58, which is a Sell signal.
-
The stock price of EYPT is 6.50 while EyePoint Pharmaceuticals 20-day SMA is 7.39, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day simple moving average is 7.70 while EYPT share price is 6.50, making it a Sell technically.
-
EYPT stock price is 6.50 and EyePoint Pharmaceuticals 200-day simple moving average is 9.28, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
14
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $6.50. The Score for EYPT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
443.6M
Price in USD:
6.50
Share Volume:
476.9K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
29.45
52-Week Low:
5.90
Sell
14
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 6.50 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 6.50 while EYPT 8-day exponential moving average is 6.63, which is a Sell signal.
-
The stock price of EYPT is 6.50 while EyePoint Pharmaceuticals 20-day EMA is 7.13, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 7.78 while EYPT share price is 6.50, making it a Sell technically.
-
EYPT stock price is 6.50 and EyePoint Pharmaceuticals 200-day simple moving average is 9.89, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.28 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is -0.46, suggesting EyePoint Pharmaceuticals is a Sell
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 39.78, which suggest EyePoint Pharmaceuticals is oversold
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (6.68 - 8.22), which suggest EyePoint Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (7.21 - 10.27), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.